Sales of weight-loss drug Ozempic are reportedly up by 500 to 600 per cent in Britain following the announcement of price rises of its popular competitor Mounjaro.
Eli Lilly, the manufacturer of Mounjaro, said prices of the drug will almost triple from 1 September to bring it in line with other countries.
